Bvf Inc An2 Therapeutics, Inc. Transaction History

Bvf Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.78 - $21.53 $902,090 - $6.99 Million	-324,493 Reduced 20.75%	1,239,470 $4.03 Million
Q4 2022 Feb 14, 2023	SELL	$8.51 - $19.69 $448,494 - $1.04 Million	-52,702 Reduced 3.26%	1,563,963 $14.9 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $15.4 $24.2 Million - $24.9 Million	1,616,665 New	1,616,665 $24.4 Million

13.5M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $19.4M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.